Pediatric Hodgkin lymphoma, version 3.2021 Guidelines


Authors: Flerlage, J. E.; Hiniker, S. M.; Armenian, S.; Benya, E. C.; Bobbey, A. J.; Chang, V.; Cooper, S.; Coulter, D. W.; Cuglievan, B.; Hoppe, B. S.; Isenalumhe, L.; Kelly, K.; Kersun, L.; Lamble, A. J.; Larrier, N. A.; Magee, J.; Oduro, K.; Pacheco, M.; Price, A. P.; Roberts, K. B.; Smith, C. M.; Sohani, A. R.; Trovillion, E. M.; Walling, E.; Xavier, A. C.; Burns, J. L.; Campbell, M.
Title: Pediatric Hodgkin lymphoma, version 3.2021
Abstract: Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings. © 2021 Harborside Press. All rights reserved.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 19
Issue: 6
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2021-06-01
Start Page: 733
End Page: 754
Language: English
DOI: 10.6004/jnccn.2021.0027
PROVIDER: scopus
PUBMED: 34214968
DOI/URL:
Notes: Export Date: 2 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anita P Price
    53 Price
Related MSK Work